MHRA/NIBSC
162 Safety Data Sheets and Chemical Risk Assessments supplied by MHRA/NIBSC.
- 1st WHO International Reference Panel For Anti-SARS-CoV2
- 4th WHO International Standard For HBV DNA For NAT
- 7th British Working Standard For Blood Coagulation
- Activated Blood Coagulation Factor XI (FXla), Human (3rd International Standard)
- ADAMTS 13 Plasma (1st International Standard)
- Alpha-1-Antitrypsin, Plasma Derived(1st International Standard)
- Anti CMV QC1 QCRCMVQC1 Sample 1
- Anti-A And Anti-B In IVIG: Positive Control (WHO Refrence Reagent)
- Anti-D For Assuring Operator And Test Performance (Working Standard)
- Anti-Granulocyte Macrophage Colony Stimulating Factor Serum
- Anti-Hepatitis B Surface Antigen(Anti-HBs)
- Anti-HIV 1 (1 In 5 BWS) Monitor Sample
- Anti-HIV Quality Control Serum Sample 2
- Anti-HLA Control
- Anti-HLA Positive Control For FCXM And Bead-Based
- Anti-HPA-1a (International Standard)
- Anti-HPA-1a Minimum Potency Reagent(2nd WHO Reference)
- Anti-HPA-3a(Minimum Potency)(WHO Reference Reagent
- Anti-HPA-5b (Minimum Potency) WHO Reference Reagen
- Anti-Human CD4 FITC Conjugated
- Anti-Human Immunodeficiency Virus 1, British Working Standard
- Anti-SARS-CoV-2 Antibodies (1st WHO International Standard)
- Antiserum To Respiratory Syncytial Virus (1st WHO International Standard)
- Antithrombin Concentrate, Human (3rd International Standard)
- Antithrombin, Plasma (3rd International Standard)
- BCG Vaccine Of Danish 1331 Sub-Strain (1st WHO Reference Reagent)
- Biotinylated Brad-5 (Bio-Brad-5) (Working Standard)
- BK Virus (BKV)(1st International Standard) For NAT
- Blood Coagulation Factor V, Plasma Human (2nd International Standard)
- Blood Coagulation Factor VIIa, Concentrate, Human (2nd International Standard)
- Blood Coagulation Factor VIII And Von Willebrand F (6th International Standard)
- Blood Coagulation Factor VIII Concentrate (8th International Standard)
- Blood Coagulation Factors II, VII, IX, X Plasma (4th International Standard)
- Bone Morphogenetic Protein-2 (Human, RDNA Derived) WHO Reference Reagent
- Brain-Derived Neurotrophic Factor (BDNF) WHO Reference Reagent
- British Working Standard For Anti-HCV
- C-Reactive Protein, Human. WHO International Standard
- C1- Inhibitor, Concentrate (1st International Standard)
- Chorionic Gonadotrophin, (5th WHO International Standard)
- Ciliary Neurotrophic Factor (Human, RDNA Derived) WHO Reference Reagent
- Clinical Virology Multiplex |: Immunodeficiency Panel
- Corticotrophin (ACTH), Porcine (3rd International
- Diphtheria Toxin 1Lf/Ml
- Diphtheria Toxoid (Adsorbed) (4th International Standard)
- Diphtheria Toxoid For Use In Flocculation Test (3rd WHO International Standard)
- Epstein-Barr Virus For Nucleic Acid Amplification
- Erythropoietin, Recombinant, For Bioassay (3rd WHO International Standard)
- Factor XIII Plasma, Human (1st International Standard)
- Factors II And X Concentrate (4th International Standard)
- FEIBA Concentrate 2nd NIBSC Working Reference Standard
- Ferritin, Human, Recombinant. (1st International Standard)
- Fibrinogen Concentrate (B) (2nd International Standard)
- Fibrinogen Plasma (D) (3rd International Standard)
- Follicle Stimulating Hormone, Human, Recombinant
- Follicle Stimulating Hormone, Luteinizing Hormone
- Follicle-Stimulating Hormone, Human, Recombinant
- Granulocyte Colony Stimulating Factor (Human RDNA Derived)
- HBsAg (HBV Genotype B4, HBsAg Subtypes Ayw1/Adw2)
- HBV,HCV,HIV Multiplex
- Hepatitis A Virus (3rd International Standard)
- Hepatitis B Surface Antigen (HBsAg) British Working Standard
- Hepatitis B Surface Antigen Subtype Adw2, Genotype
- Hepatitis C Virus (HCV) For NAT
- HIV-1 RNA (4th International Standard)
- HIV-2 (Antibody) Monitor Sample
- HTLV-1 (Antibody) Monitor Sample
- Human Blood Factor IX Concentrate (5th International Standard)
- Human Coxsackie B4 For NAT
- Human Cytomegalovirus (HCMV) For NAT
- Human Immunodeficiency Virus Type 2 RNA (HIV-2) NAT
- Human Measles Mvi/Moscow Rus/1988 Genotype A Virus
- Human Metapneumovirus Working Reagent For NAT
- Human Papillomavirus (HPV) Type 33 DNA (1st WHO International Standard)
- Human Parechovirus Working Reagent For NAT
- Human Respiratory Syncytial Virus A2 For NAT
- Human Rhinovirus Genogroup A Working Reagent For NAT
- Influenza Virus (A/Christchurch/1/2003, H1N1) For NAT
- Influenza Virus (A/Wyoming/3/2003, H3N2) For NAT
- Influenza Virus (B/Jiangsu/10/2003) For NAT
- Interferon Beta (Human, RDNA, Glycosylated) (3rd International Standard)
- Interferon Beta SER17 Mutein (Human, RDNA Derived)
- Interleukin- 2 (Human, RDNA Derived) (2nd International Standard)
- Interleukin-29 (Interferon Lambda, Human, RDNA Derived) WHO Reference Reagent
- Low Molecular Weight Heparin (3rd International Standard)
- Low Molecular Weight Heparin For Molecular Weight (2nd International Standard)
- Luteinizing Hormone, Human, Pituitary (3rd WHO International Standard)
- Monitor Sample For HBsAg 0.05IU/Ml
- NIBSC Anti-SARS-CoV-2 Antibody Diagnostic Calibrant
- Non WHO Reference Material ICS Positive Control Cells
- Norovirus GIl Working Reagent For NAT
- Nucleic Acid Amplification Technique (NAT) Panel For SARS CoV2
- Panel Of Recombinant Antibody Controls For Cytokine Release Assays - 1
- Panel Of Recombinant Antibody Controls For Cytokine Release Assays - 2
- Panel Of Recombinant Antibody Controls For Cytokine Release Assays - 3
- Panel Of Recombinant Antibody Controls For Cytokine Release Assays - 4
- Panel Of Recombinant Antibody Controls For Cytokine Release Assays - 5
- Panel Of Recombinant Antibody Controls For Cytokine Release Assays - 6
- Parainfluenza Virus Serotype 1 For NAT
- Parainfluenza Virus Serotype 2 For NAT
- Parainfluenza Virus Serotype 3 For NAT